SYNLAB Value Stock - Dividend - Research Selection
Market price: 20,70 EUR
Synlab AG Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||520.414.000|
|Free cash flow||425.502.016|
|Liabilities & Shareholders equity||5.283.000.000|
|Diluted shares outstanding||221.368.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||5.557.692.416,00 USD|
|Sectors||Health Care Services|
|Raw Data Source||IFRS in Millionen EUR|
Description of the company
SYNLAB AG provides clinical laboratory and medical diagnostic services for practicing doctors, clinics, patients, and the pharmaceutical industry primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 450 laboratories and 1,600 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.